Publisher: Elsevier

Related content
Volume 11, Number 5, 1 October 1999

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Immunology - Paper alert
pp. 475-483(9)
Authors: Elliott, T.; Bonneville, M.; Kruisbeek, A.; Liu, Y.; Ono, S.; Rodosevich, M.; Rowland-Jones, S.; Casanova, J.; Walker, P.R.; Wood, K.; Bushell, A.

Favourites:Add to Favourites

Transplantation: Cancer - Web alert
pp. 485-485(1)
Author: Greaves, D.R.

Favourites:Add to Favourites
Favourites:Add to Favourites
Favourites:Add to Favourites

What is the role of regulatory T cells in transplantation tolerance?
pp. 497-503(7)
Authors: Zhai, Y.; Kupiec-Weglinski, J.W.

Favourites:Add to Favourites
Favourites:Add to Favourites

New strategies for preventing graft-versus-host disease
pp. 509-515(7)
Authors: Murphy, W.J.; Blazar, B.R.

Favourites:Add to Favourites

Tolerance to vascularized organ allografts in large-animal models
pp. 516-520(5)
Authors: Kawai, T.; Sachs, D.H.; Cosimi, A.B.

Favourites:Add to Favourites

Effect of HLA mismatches on the outcome of hematopoietic transplants
pp. 521-526(6)
Authors: Petersdorf, E.W.; Mickelson, E.M.; Anasetti, C.; Martin, P.J.; Woolfrey, A.E.; Hansen, J.A.

Favourites:Add to Favourites

Recent advances in xenotransplantation
pp. 527-531(5)
Authors: Sandrin, M.S.; McKenzie, I.F.

Favourites:Add to Favourites
Favourites:Add to Favourites

Cancer - Editorial overview
pp. 539-540(2)
Author: Vitetta, E.

Favourites:Add to Favourites

Signaling antibodies in cancer therapy
pp. 541-547(7)
Authors: Cragg, M.S.; French, R.R.; Glennie, M.J.

Favourites:Add to Favourites

Recombinant antibody constructs in cancer therapy
pp. 548-557(10)
Author: Hudson, P.J.

Favourites:Add to Favourites

Bispecific antibodies in cancer therapy
pp. 558-562(5)
Authors: Segal, D.M.; Weiner, G.J.; Weiner, L.M.

Favourites:Add to Favourites

A new era for radiolabeled antibodies in cancer?
pp. 563-569(7)
Authors: denardo, S.J.; Kroger, L.A.; denardo, G.L.

Favourites:Add to Favourites

Immunotoxins in cancer therapy
pp. 570-578(9)
Author: Kreitman, R.J.

Favourites:Add to Favourites

Developments with targeted enzymes in cancer therapy
pp. 579-583(5)
Authors: Bagshawe, K.D.; Sharma, S.K.; Burke, P.J.; Melton, R.G.; Knox, R.J.

Favourites:Add to Favourites

Monoclonal antibody drug conjugates in the treatment of cancer
pp. 584-588(5)
Authors: Trail, P.A.; Bianchi, A.B.

Favourites:Add to Favourites

Optimism after much pessimism: what next? - Commentary
pp. 589-591(3)
Authors: Milstein, C.; Waldmann, H.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more